170542 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
BIOMARKERS
#2NASAL CAVITY SAMPLING METHODS AND APPARATUS
#3METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE
#4Use of Salvianolic Acid E in the Preparation of Drugs Targeting Senescent Cells, Inhibiting Tumors or Extending Lifespan
#5PAPER-BASED MICROFLUIDIC CHIP FOR MEASUREMENT OF CYSTATIN C IN PLASMA AND SERUM (CYS-C PAPER CHIP)
#6MONITORING INFLAMMATION STATUS
#7METHOD FOR DETECTING ALZHEIMER'S DISEASE, AND DETECTION REAGENT
#8METHOD FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER, SYSTEM FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER
#9ESM1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#10SFLT1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#11PRESEPSIN MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#12WASTEWATER-BASED EPIDEMIOLOGY METHODS FOR ASSESSING POPULATION HEALTH
#13METHODS AND COMPOSITIONS FOR DIFFERENTIATING PROGRESSIVE CHRONIC KIDNEY DISEASE FROM STABLE CHRONIC KIDNEY DISEASE
#14METHODS FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN THE PLASMA FRACTION OF A SAMPLE OF WHOLE BLOOD
#15EYE DISEASE MARKER
#16NASAL CAVITY SAMPLING METHODS AND APPARATUS
#17BIOMARKERS IN THE SELECTION OF THERAPY OF HEART FAILURE
#18Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#19METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS
#20B-cell epitope of cysteine protease inhibitor, hybridoma cell line, monoclonal antibody and uses thereof
#21METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF RENAL DISEASE AND PERIODONTAL DISEASE
#22Diagnosis and treatment of autoimmune diseases
#23COMPOSITIONS AND METHODS FOR DETECTING ALLERGENS
#24PREDICTIVE BIOMARKERS FOR TREATMENT OF EYE DISEASES
#25EXTRACELLULAR VESICLE MARKERS FOR STABLE ANGINA AND UNSTABLE ANGINA
#26Diagnosis and treatment of autoimmune diseases
#27Method and System for the Diagnosis, Prevention or Treatment of Alzheimer s and Related Disease by Measuring, Inhibiting or Arresting Amyloid Plaque Development
#28Method of diagnosis
#29Method of Determining Risk of an Adverse Cardiac Event
#30IGFBP7 for prediction of risk of AKI when measured prior to surgery
#31METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS
#32Measurement method, and measuring chip and measuring kit used for the same
#33METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS
#34Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#35ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS
#36Methods and compositions for the detection and diagnosis of renal disease and periodontal disease
#37METHOD FOR MONITORING CATHEPSIN S INHIBITION
#38Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
#39METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS
#40PEPTIDOMIMETIC COMPOUNDS AND RELATED METHODS
#41Diagnosis and treatment of autoimmune diseases
#42Methods and Devices for Detecting Kidney Damage
#43Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#44Systems And Methods For Early Detection Of Cervical Cancer By Multiplex Protein Biomarkers
#45ACUTE KIDNEY INJURY
#46METHODS FOR DIAGNOSING AND/OR TREATING STERILITY
#47BIOMARKERS FOR BREAST CANCER PREDICTION AND DIAGNOSIS
#48Marker peptide for determining risk of hyperglycemia and use thereof
#49Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#50BIOMARKERS FOR THE PROGNOSIS OF ISCHEMIC STROKE
#51Kidney disease biomarker
#52BIOMARKERS FOR COLORECTAL CANCER DIAGNOSIS AND PREDICTION
#53BIOMARKERS FOR BREAST CANCER PREDICTIONS AND DIAGNOSES
#54METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS
#55Use of a cysteine protease of plasmodium vivax
#56Determination of Exosomel Biomarkers for Predicting Cardiovascular Events
#57BIOMARKERS AND ASSAYS FOR DIABETES
#58TARGETS FOR TREATMENT OF CHLAMYDIAL INFECTIONS
#59Method for measuring cystatin C in human body fluid
#60Methods and Devices for Detecting Kidney Transplant Rejection
#61Cystatin C adsorption inhibitor
#62Biomarker for diagnosis of liver disease
#63Devices for Detecting Renal Disorders
#64Methods and Devices for Detecting Kidney Damage
#65Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#66Computer Methods and Devices for Detecting Kidney Damage
#67Methods and devices for detecting obstructive uropathy and associated disorders
#68Methods and Devices for Detecting Glomerulonephritis and Associated Disorders
#69Use of a cysteine protease of Plasmodium vivax
#70Turbidimetric immunoassay for assessing human Cystatin C
#71Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease
#72Turbidimetric immunoassay for assessing human Cystatin C
#73Method for diagnosis and prognosis of epithelial cancers
#74Methods of diagnosing or prognosing Alzheimer's disease
#75Compounds and methods to enhance rAAV transduction
#76Panel of biomarkers for peripheral arterial disease
#77Method of screening for agents that modulate Tysnd1 level or activity in a cell.
#78METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS
#79Method of cancer treatment by p53 protein control
#80Non-invasive assessment of intra-amniotic environment
#81Modulation of the neuroendoctrine system as a therapy for motor neuron disease
#82Compounds and methods to enhance rAAV transduction
#83Detection and identification of saxiphilins using saxitoxin-biotin conjugates